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1946REPLY: Going Over LEGACY With a
Pinch of SaltWe thank Dr. Valentova and colleagues for high-
lighting some of the key ﬁndings of the LEGACY
(Long-term Effect of Goal-directed weight manage-
ment in an Atrial ﬁbrillation Cohort studY). This
study demonstrates that in overweight and obese
individuals with symptomatic atrial ﬁbrillation (AF),
weight loss had a dose-dependent effect on the long-
term freedom from AF (1). This was an observational
registry in which measurement and sampling bias was
minimized through standardized processes, evalua-
tion by blinded operators, and the routine collection
of outcome data. Details of patient ﬂow and attrition
are provided in the manuscript.
Controversy does exist regarding long-term sus-
tainability of weight loss. Indeed, greater weight loss
corresponded with higher participation in the weight
management clinic. In addition, the weight loss ach-
ieved in patients attending the dedicated clinic was
progressive and sustained with less ﬂuctuation. It is
incorrect to suggest that the results of this study are
an epiphenomenon due to higher compliance.
Improved lipid proﬁle, blood pressure, and glycemic
control were evident with weight loss, with the use of
fewer medications. In this series we did not have
consistent data on follow-up polysomnography;
however, in a smaller series we have presented that
weight loss reduced sleep apnea (2).
The numbers and type of antiarrhythmic drugs
used were not different at baseline. At ﬁnal follow-up
the number of antiarrhythmic drugs used was
signiﬁcantly lower with increasing weight loss. No
patient remained on amiodarone. The numbers of
ablation procedures performed in 3 groups were not
different. There were no deaths in this study.
It has been suggested that propensity score
matching (PSM) be used to mitigate potential biases
to maintain a balanced design. The baseline charac-
teristics of this cohort demonstrated no differences in
means, proportions, and distributions between the
3 weight loss groups. Thus, using PSM would not
have resulted in a signiﬁcantly higher balance to that
which is already observed. The most important
reservation in using PSM in the current analysis is the
sample size. PSM is a large sample tool and its use in
the current dataset may in fact increase the unbal-
ance among the covariates. This loss was considered
unwise given the potential nonsigniﬁcant improve-
ment in the balance between the groups.
Finally, we agree on the need for a randomized
control multicenter trial—which is underway. How-
ever, it is important to realize that the impact ofweight ﬂuctuation on AF burden cannot be evaluated
in a randomized study design. While we can argue on
the mechanisms and vacillate, given the expanding
epidemic of obesity and AF, it is prudent that primary
and secondary prevention strategies be instigated
urgently. Evidently, aggressive risk factor manage-
ment with weight loss and increased physical activity
are crucial elements in the management of AF (2,3).Rajeev K. Pathak, MBBS
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RegurgitationIn their review of secondary mitral regurgitation (MR),
Asgar et al. (1) attribute abnormal leaﬂet tethering
largely to apical and lateral papillary muscle displace-
ment. To our knowledge the ﬁrst comprehensive
quantitative echocardiographic study of this topic was
reported in 1983 (2). In that study no difference was
found in chordal eccentricity, papillary muscle teth-
ering length, and left ventricular volume between MR
and no-MR groups. Instead, the abnormal, apically
displaced tethering associatedwithMR derived almost
exclusively from annular dilation, in association with
